miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor-Reference-Cited by-同舟云学术

miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor

Published:2016-05-31 Issue:10 Volume:20 Page:1974-1983
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Qin Qin¹²,Wei Furong³,Zhang Jianbo⁴,Wang Xingwu⁵,Li Baosheng¹²

Affiliation:

1. Department of Radiation Oncology (Chest Section) Shandong Cancer Hospital and Institute Shandong University Jinan China

2. Department of Radiation Oncology (Chest Section) Shandong Cancer Hospital and Institute Shandong Academy of Medical Sciences Jinan China

3. Institute of Basic Medicine Shandong Academy of Medical Sciences School of Medicine and Life Sciences University of Jinan‐Shandong Academy of Medical Sciences Jinan China

4. Department of Pathology Shandong Cancer Hospital and Institute Shandong University Jinan China

5. Basic Research Center Shandong Cancer Hospital and Institute Shandong University Jinan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12889

Reference41 articles.

1. Cancer treatment and survivorship statistics, 2012

2. Non–Small Cell Lung Cancer, Version 6.2015

3. The quest to overcome resistance to EGFR-targeted therapies in cancer

4. Targeting the epidermal growth factor receptor in cancer: apoptosis takes center stage;Kari C;Cancer Res,2003

5. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs and exosomal non-coding RNAs in lung cancer: insights into their functions;Frontiers in Cell and Developmental Biology;2024-05-27

2. Emerging role of tumor suppressing microRNAs as therapeutics in managing non-small cell lung cancer;Pathology - Research and Practice;2024-04

3. The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer;Pathology - Research and Practice;2024-01

4. Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis;Translational Oncology;2023-07

5. Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review;Frontiers in Oncology;2022-12-21